Skip to main content
×
Home
    • Aa
    • Aa

Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids

  • Tal Koppelmann (a1) (a2), Yulia Pollak (a1), Jorge Mogilner (a3), Jacob Bejar (a4), Arnold G. Coran (a5) and Igor Sukhotnik (a1) (a3)...
Abstract

Growing evidence suggests that n-3 PUFA and their specific lipid mediators can reduce the activity of inflammatory processes. In the present study, we evaluated the effects of oral n-3 PUFA supplementation on intestinal structural changes, enterocyte proliferation and apoptosis during methotrexate (MTX)-induced intestinal damage in the rat. A total of thirty-two male rats were divided into four experimental groups: control (CONTR) rats; CONTR-n-3 PUFA rats treated with oral administration of n-3 PUFA at a dose of 300 μg/kg once per d 72 h before and 72 h following vehicle injection; MTX rats treated with a single dose of MTX; MTX-n-3 PUFA rats treated with oral n-3 PUFA following the injection of MTX. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation and enterocyte apoptosis determined 72 h following MTX injection. Real-time PCR was used to determine B-cell lymphoma 2 (Bcl2)-associated X protein (Bax) and Bcl2 mRNA expression. Western blotting was used to determine phosphorylated extracellular signal-related kinase, β-catenin, Bax and Bcl2 protein levels. MTX-n-3 PUFA rats demonstrated a greater jejunal and ileal bowel weight, greater ileal mucosal weight, greater ileal mucosal DNA and protein levels, greater villus height in the jejunum and ileum and crypt depth in the ileum, compared with MTX animals. A significant decrease in enterocyte apoptosis in the ileum of MTX-n-3 PUFA rats (v. MTX) was accompanied by decreased Bax mRNA and protein expression and increased Bcl2 mRNA levels. Thus, the treatment with oral n-3 PUFA prevented mucosal injury and improved intestinal recovery following MTX-injury in rats.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr I. Sukhotnik, fax +972 4 8359620, email igor-dr@internet-zahav.net
References
Hide All
1Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl., 560S569S.
2Weber PC, Fischer S, von Schacky C, et al. (1986) Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In Health Effects of Polyunsaturated Fatty Acids in Sea Foods, pp. 4960 [, editors]. Orlando, FL: Academic Press.
3Ekema G, Falchetti D, Boroni G, et al. (2008) Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids). J Pediatr Surg 43, 11911195.
4Eisner F, Jacob P, Frick JS, et al. (2011) Immunonutrition with long-chain fatty acids prevents activation of macrophages in the gut wall. J Gastrointest Surg 15, 853859.
5Meydani SN, Lichtenstein AH, Cornwall S, et al. (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92, 105113.
6Loeschke K, Ueberschaer B & Pietsch A (1996) n-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41, 20872094.
7Aslan A & Triadafilopoulos G (1992) Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87, 432437.
8Kremer JM, Lawrence DA, Petrillo GF, et al. (1995) Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs: clinical and immune correlates. Arthritis Rheum 38, 11071114.
9Geusens P, Wouters C, Nijs J, et al. (1994) Long term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis: a 12 month, double blind, controlled study. Arthritis Rheum 37, 824829.
10Schmöcker C, Weylandt KH, Kahlke L, et al. (2007) Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 45, 864869.
11Sonis ST (1993) Complications of cancer and their treatment: oral complications. In Cancer Medicine, 3rd ed., pp. 23812388 [, editors]. Philadelphia: Lea and Febiger.
12Naidu MU, Ramana GV, Rani PU, et al. (2004) Chemotherapy-induced and/or radiation therapy-induced oral mucositis? Complicating the treatment of cancer. Neoplasia 6, 423431.
13Sonis ST, Elting LS, Keefe DMK, et al. (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 19952025.
14Kesik V Uysal B, Kurt B, et al. (2009) Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biol Ther 8, 16231628.
15Dyerberg J, Bang HO & Hjorne N (1975) Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28, 958967.
16Simopoulos AP, Kifer RR, Wykes AA, et al. (1991) Omega 3 fatty acids: research advances and support in the field since June 1985 (worldwide). World Rev Nutr Diet 66, 5171.
17Levy AE & Alexander JW (1995) Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and CsA. Transplantation 60, 812815.
18Calder PC, Yaqoob P, Harvey DJ, et al. (1994) The incorporation of fatty acids by lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 300, 509518.
19Yaqoob P, Newsholme EA & Calder PC (1995) Influence of cell culture conditions on diet-induced changes in lymphocyte fatty acid composition. Biochim Biophys Acta 1255, 333340.
20Lewis RA, Lee TH & Austen KF (1986) Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In Health Effects of Polyunsaturated Fatty Acids in Sea Foods, pp. 227238 [, editors]. Orlando, FL: Academic Press.
21Shoda R, Matsueda K, Yamato S, et al. (1995) Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 30, Suppl. 80, 98101.
22Hillier K, Jewell R, Dorrell L, et al. (1991) Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32, 11511155.
23Haegebarth A & Clevers H (2009) Wnt signaling, Lgr5, and stem cells in the intestine. Am J Pathol 174, 1521.
24Sukhotnik I, Mogilner J, Karry R, et al. (2009) Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in a rat. Digestion 79, 513.
25Sukhotnik I, Mogilner JG, Shteinberg D, et al. (2009) Leptin accelerates enterocyte turnover during methotrexate-induced intestinal mucositis in a rat. Cancer Biol Ther 8, 17.
26Calder PC (2009) Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol 28, 506534.
27Calderaro V, Parrillo C, Balestrieri ML, et al. (1994) Docosahexaenoic acid and signaling pathways in rabbit colon. Mol Pharmacol 45, 737746.
28Pearson G, Robinson F, Beers Gibson T, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22, 153183.
29Logan RM, Stringer AM, Bowen JM, et al. (2008) Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7, 11391145.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 8
Total number of PDF views: 50 *
Loading metrics...

Abstract views

Total abstract views: 152 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.